Hypertrophic Cardiomyopathy Sudden Death in Hypertrophic Cardiomyopathy: Identification of High Risk Patients

نویسندگان

  • Perry M. Elliott
  • Shaughan Dickie
  • Sanjay Sharma
  • Amanda Varnava
  • Niall G. Mahon
  • William J. McKenna
چکیده

OBJECTIVES We sought to identify patients with hypertrophic cardiomyopathy (HCM) at high risk of sudden death (SD). BACKGROUND Relatively low mortality rates in HCM make conventional analysis of multiple clinical risk markers for SD problematic. This study used a referral center registry to investigate a smaller number of generally accepted noninvasive risk markers. METHODS We studied 368 patients (14 to 65 years old, 239 males) with HCM. There were five variables: nonsustained ventricular tachycardia (NSVT), syncope, exercise blood pressure response (BPR), family history of sudden death (FHSD) and left ventricular wall thickness (LVWT). RESULTS During follow-up (3.6 6 2.5 years [range 2 days to 9.6 years]), 36 patients (9.8%) died, 22 of them suddenly. Two patients received heart transplants. The six-year SD-free survival rate was 91% (95% confidence interval [CI] 87% to 95%). In the Cox model, there was a significant pairwise interaction between FHSD and syncope (p 5 0.01), and these were subsequently considered together. The multivariate SD risk ratios (with 95% CIs) were 1.8 for BPR (0.7 to 4.4) (p 5 0.22); 5.3 for FHSD and syncope (1.9 to 14.9) (p 5 0.002); 1.9 for NSVT (0.7 to 5.0) (p 5 0.18) and 2.9 for LVWT (1.1 to 7.1) (p 5 0.03). Patients with no risk factors (n 5 203) had an estimated six-year SD-free survival rate of 95% (95% CI 91% to 99%). The corresponding six-year estimates (with 95% CIs) for one (n 5 122), two (n 5 36) and three (n 5 7) risk factors were 93% (87% to 99%), 82% (67% to 96%) and 36% (0% to 75%), respectively. Patients with two or more risk factors had a lower six-year SD survival rate (95% CI) compared with patients with one or no risk factors (72% [56% to 88%] vs. 94% [91% to 98%]) (p 5 0.0001). CONCLUSIONS This study demonstrates that patients with multiple risk factors have a substantially increased risk of SD sufficient to warrant consideration for prophylactic therapy. (J Am Coll Cardiol 2000;36:2212–8) © 2000 by the American College of Cardiology

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Apical Hypertrophic Cardiomyopathy in a Case with Chest Pain and Family History of Sudden Cardiac Death: A Case Report

Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiovascular disease, which is caused by a multitude of mutations in genes encoding proteins of the cardiac sarcomere (1). Apical hypertrophic cardiomyopathy (AHCM) is an uncommon type of HCM. The sudden cardiac death is less likely to occur in the patients inflicted with AHCM (2). Herein, we presented the case of a 29-year-old man ...

متن کامل

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk.

T he incidence of sudden death in hypertrophic cardiomyopathy is 2-4% a year in adults and 4-6% a year in children and adolescents.1 These data have been generated from referral cardiac centers and may reflect a bias to the more severe patients.2 The identification and management of patients with hypertrophic cardiomyopathy who are at increased risk of sudden death remains a major problem, part...

متن کامل

Risk stratification and prevention of sudden death in hypertrophic cardiomyopathy.

Sudden unexpected death, often occurring in young, asymptomatic patients, is the most devastating facet of the natural history of hypertrophic cardiomyopathy, and appears to be the consequence of primary ventricular tachyarrhythmias arising in an electrically unstable myocardial substrate characterized by disorganized cellular architecture, ischemia, cell death, and replacement scarring. Althou...

متن کامل

Investigation of Polymorphisms in Non-Coding Region of Human Mitochondrial DNA in 31 Iranian Hypertrophic Cardiomyopathy (HCM) Patients

The D-loop region is a hot spot for mitochondrial DNA (mtDNA) alterations, containing two hypervariable segments, HVS-I and HVS-II. In order to identify polymorphic sites and potential genetic background accounting for Hypertrophic CardioMyopathy (HCM) disease, the complete non-coding region of mtDNA from 31 unrelated HCM patients and 45 normal controls were sequenced. The sequences were aligne...

متن کامل

Prognosis of Hypertrophic Cardiomyopathy

INTRODUCTION Background: The actual prognosis of hypertrophic cardiomyopathy, a disorder previously thought of to be notorious for an increased risk of untimely death is poorly defined. Objective: The present study describes the findings of patients with Hypertrophic Cardiomyopathy followed for more than nineteen years in a large clinic population. Materials and Methods: A clinic population of ...

متن کامل

Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.

Although patients with hypertrophic cardiomyopathy (HCM) and without conventional risk factors for sudden death are generally considered at low risk, the magnitude of risk in such patients remains unknown, and additional markers of prognosis may permit more accurate risk stratification.1–3 We report a patient with HCM and without conventional risk factors who had a sustained life-threatening ve...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2000